2026.05.14 LinqMed Selected for the UK Program Following the Pitch Contest at the Nakanoshima Qross Innovation Challenge
2025.12.24 Demonstration of the Efficacy of Hypoxia-Targeted Local Radiotherapy for Malignant Brain Tumors